Cargando…
Ovarian cancer: what’s new, where next?
The recent RDOG studies have confirmed the value of CT in the management of ovarian cancer. However we now know that metastases to the ovary may exactly mimic primary cancer. This demands a firm histological diagnosis when surgery is not planned and especially with a history of breast and gastrointe...
Autor principal: | A Spencer, John |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
e-MED
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1434523/ https://www.ncbi.nlm.nih.gov/pubmed/18211856 http://dx.doi.org/10.1102/1470-7330.2003.0030 |
Ejemplares similares
-
Ovarian cancer in the older patient: where are we now? What to do next?
por: Rousseau, Frédérique, et al.
Publicado: (2023) -
Albumin administration in the acutely ill: what is new and where next?
por: Vincent, Jean-Louis, et al.
Publicado: (2014) -
Mimicking exercise: what matters most and where to next?
por: Hawley, John A., et al.
Publicado: (2020) -
Erratum to: Albumin administration in the acutely ill: what is new and where next?
por: Vincent, Jean-Louis, et al.
Publicado: (2014) -
Pediatric Laryngopharyngeal Reflux in the Last Decade: What Is New and Where to Next?
por: Sofokleous, Valentinos, et al.
Publicado: (2023)